Seong Kim, PhD

Contact Us

LSU Health Shreveport
Department of Microbiology & Immunology
1501 Kings Hwy
Shreveport, LA 71103


(318) 675-4505
(318) 675-5111
(318) 675-5764

Seong K. Kim, PhD

Research Associate Professor of Microbiology and Immunology

Bachelor of Science, Molecular Biology/Zoology (1985) - Seoul National University, Korea
Master of Science, Molecular Biology/Virology (1988) - Seoul National University, Korea
PhD, Molecular Biology/Virology (1992) - Seoul National University, Korea
Postdoctoral Fellow (1993) - LSU Health Science Center-Shreveport


The Kim lab recently published papers in Journal of Virology and Antiviral Research.

Antiviral Research journal



Major Research Interests:  gene regulation and innate immune response of two Alphaherpesviruses equine herpesvirus 1 (EHV-1) and varicella-zoster virus (VZV).

Equine herpesvirus 1 (EHV-1) is an important pathogen of equines and a useful model to investigate Alphaherpesvirus gene regulation as its gene program is initiated by a single immediate-early protein (IEP) which activates expression of >50 early (E) genes. The IEP possesses several domains essential for trans-activation, including an acidic trans-activation domain (TAD) and binding domains for DNA and general transcription factors. However, the mechanism by which the IEP TAD functions in activating transcription remains unknown. We hypothesize that the IEP interacts with TBP, TFIIB, and TFIIA, and that its TAD mediates gene expression by recruiting components of the RNA polymerase II machinery, such as Mediators and TBP-associated factors (TAFs). We are also interested in understanding the protective mechanisms elicited by attenuated EHV-1 KyA in CBA mice. EHV-1 KyA immunization effectively protected CBA mice from pathogenic RacL11 challenge by inducing the expression of the IFN-γ gene and 16 interferon-stimulated genes (ISGs). These results suggest that KyA is a strong candidate as a live attenuated EHV-1 vaccine in horses. Evaluation of each ISGs expressed in recombinant Adenovirus will identify the ISG(s) with maximal antiviral activity and allow experiments to define its mechanism of antiviral function.  These findings may reveal new and novel targets to inhibit herpesvirus replication.

Varicella-zoster virus (VZV) is a ubiquitous human pathogen that establishes latency in sensory ganglia; upon reactivation, the virus migrates to the skin via axonal transport to cause zoster (shingles). IFN-γ is a potent cytokine produced following primary VZV infection. How VZV overcomes this cutaneous IFN-γ barrier and produces skin vesicles is not known. Our results showed that IFN-γ effectively inhibited VZV replication and immediate-early 62 protein (IE62)-mediated trans-activation in lung epithelial A549 and retinal epithelial ARPE-19 cells but not in skin melanoma MeWo cells. IE62, a major viral trans-activator, initiates the virus life cycle and is a key component of pathogenesis. These results led us to hypothesize that IFN-γ blocks VZV replication by inhibiting IE62 function. Functional mechanisms of IFN-γ in VZV replication could provide important information to control VZV replication and pathogenesis, but also identify factors contributing to the tissue restriction of VZV.


Selected Publications

  1. Kim, S. K., A. K. Shakya, and D. J. O’Callaghan. 2019. Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response. Antiviral Research. Antiviral Research. In press. PMID: 31247247
  2. Shakya, A. K., D. J. O’Callaghan, and S. K. Kim. 2019. Interferon gamma inhibits varicella-zoster virus replication in a cell line-dependent manner. J. Virol: 93(12):e00257-19. PMID: 30918075
  3. Shakya, A. K., D. J. O’Callaghan, and S. K. Kim. 2017. Comparative genomic sequencing and pathogenic properties of equine herpesvirus 1 KyA and RacL11. Front. Vet. Sci. 4:211. PMID: 29312962
  4. Kim, S. K., A. K. Shakya, and D. J. O’Callaghan. 2016. Immunization with attenuated equine herpesvirus 1 strain KyA induces innate immune responses that protect mice from lethal challenge. Journal of Virology 90: 8090-8104. PMID: 27356904
  5. Kim, S. K., A. K. Shakya, and D. J. O’Callaghan. 2016. Full trans-activation mediated by the immediate-early protein of equine herpesvirus 1 requires a consensus TATA box, but not its cognate binding sequence. Virus Research 211:222-232. PMID: 26541315
  6. Kim, S. K., A. K. Shakya, S. Kim, and D. J. O’Callaghan. 2016. Functional characterization of the serine-rich tract of varicella-zoster virus IE62. Journal of Virology 90:959-971. PMID: 26537679
  7. Zhang, Y., R. A. Charvat, S. K. Kim, and D. J. O’Callaghan. 2014. The EHV-1 UL4 protein that tempers viral gene expression interacts with cellular transcription factors. Virology 449:25-34.
  8. Kim, S., G. Dai, D. J. O’Callaghan, and S. K. Kim. 2012. Characterization of cis-acting elements required for autorepression of the equine herpesvirus 1 IE gene. Virus Research 165:52-60.
  9. Kim, S. K., S. Kim, G. Dai, Y. Zhang, B. C. Ahn, and D. J. O'Callaghan. 2011. Identification of functional residues of the IR2 protein of equine herpesvirus 1 required for inhibition of viral gene expression and replication. Virology 417:430-442. PMID: 21794889
  10. Kim, S. K., B. C. Ahn, R. A. Albrecht, and D. J. O'Callaghan. 2006. The unique IR2 protein of equine herpesvirus 1 (EHV-1) negatively regulates EHV-1 gene expression. J. Virol. 80:5041-5049. PMID: 16641295

Complete List of my Published Work in MyBibliography:


Seong Kim, PhD
Seong Kim, PhD

Principle Investigator

The Kim Laboratory seeks to understand gene regulation and innate immune response of two Alphaherpesviruses equine herpesvirus 1 and varicella-zoster virus.


Post-doctoral Fellows

While we are not currently recruiting Post-doctoral Fellows, quality candidates will always be considered.  To enquire about opportunities, contact Dr. Kim at

Kim Lab

Kim Lab

Kim Lab

Kim Lab